MPR Weekly Dose Podcast #122
New nasal spray for allergic rhinitis; weight management drug indication is expanded to include teens; monkeypox vaccine access; COVID-19 antibody shelf-life extension; JUUL banned in the US.
Immunization
HHS Expands Access to Jynneos Vaccine in Light of Monkeypox Outbreak
In total, 1.6 million doses of the Jynneos vaccine will be available this year.
Fourth Dose of BNT162b2 Prevents Severe COVID-19 in Nursing Home Residents
Substantial protection against hospitalizations, deaths seen among long-term care facility residents during omicron surge
Pfizer-BioNTech Omicron-Adapted COVID-19 Vaccine Candidates Elicit Strong Immune Response
The trial evaluated booster doses of the Omicron-adapted vaccine candidates.
COVID-19 Vaccine Does Not Increase CV Event Risk in Those With Existing Disease
Findings show safety of BNT162b2 or CoronaVac vaccines in patients with cardiovascular disease
Increase in HPV Vaccination Rates Among Teens Seen From 2015 to 2020
Larger increases in coverage seen among boys than girls, with narrowing of coverage gap
CDC Backs Moderna Vaccine for Those Aged 6 to 17
ACIP endorsed the shots after hearing the latest evidence on the vaccine’s effectiveness
New York City Opens First Monkeypox Vaccine Clinic in US
Announcement follows similar ones issued from the United Kingdom and Canada
CDC Panel Urges Seniors to Get New, More Potent Flu Shot This Fall
Agency urges all Americans aged 6 months and older to get a flu shot every season
